TREATMENT OF HEPATOBLASTOMA

Fourteen patients with hepatoblastoma were treated at Gunma University Hospital and Gunma Children's Hospital Medical Center between 1966 and December 1992. The ages of the patients, 13 boys and 1 girl, ranged from 2 months to 10 years (median 1 year). The tumor was stage I in 2 patients, II in 5, IIIA in 2, IIIB in 4, and IV in one patient. The histological type was well differentiated in 6 and poorly differentiated in 4 (unknown in 4). Macroscopically, the tumor was resected in 9 of 11 patients who underwent operation. Intraarterial infusion of adriamycin or mitomycin C was done in 5 patients and embolization of the hepatic artery was also performed in 3. Chemotherapy was used in 11 patients but radiation (16-40Gy) only in 3. At the time of evaluation, January 1993, 7 out of 9 patients whose tumor was resected survived without any evidence of disease. Six patients died of disease between 1 and 8 months after treatment. One patient died of recurrent disease 5 years after treatment. Postoperative complications included portal hypertension with esophageal varices. Hemihypertrophy was observed in 2 patients.

[1]  J. Quinn,et al.  Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  J. Quinn,et al.  The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy. , 1991, Journal of pediatric surgery.

[3]  A. Cangır,et al.  Marked response to preoperative high-dose cis-platinum in children with unresectable hepatoblastoma. , 1991, Journal of pediatric surgery.

[4]  R. Andrassy,et al.  Aggressive excision of pulmonary metastases is warranted in the management of childhood hepatic tumors. , 1991, Journal of pediatric surgery.

[5]  T. Honna,et al.  Treatment of disseminated hepatoblastoma involving bilateral lobes. , 1990, Journal of pediatric surgery.

[6]  K. Muczynski,et al.  Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma , 1989, Cancer.

[7]  J. Quinn,et al.  Adriamycin and cisplatin for hepatoblastoma , 1985, Cancer.

[8]  M. Shipp,et al.  Effective cisplatin (DDP) based chemotherapy in the treatment of hepatoblastoma. , 1985, Medical and pediatric oncology.

[9]  M. Finegold,et al.  Primary hepatic tumors of childhood. , 1983, Human pathology.

[10]  M. Weinblatt,et al.  Preoperative chemotherapy for unresectable primary hepatic malignancies in children , 1982, Cancer.

[11]  H. Sather,et al.  Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5‐fluorouracil) in the treatment of children with malignant hepatoma , 1982, Cancer.

[12]  B. M. Henderson Histologic classification of liver-cell carcinoma in infancy and childhood and its clinical evaluation : M. Kasai and I. Watanabe. Cancer 25:551–563 (March), 1970 , 1971 .

[13]  W. Newton,et al.  Classification of primary malignant tumors of liver in infancy and childhood , 1967, Cancer.

[14]  K. Ishak,et al.  Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases , 1967, Cancer.